Aqueel Shahid , Sadia Abdullah , Abbas Ali Hussain , Sadia Khan
{"title":"青少年罕见病例:青少年鼻窦畸胎瘤肉瘤及其临床病程","authors":"Aqueel Shahid , Sadia Abdullah , Abbas Ali Hussain , Sadia Khan","doi":"10.1016/j.rcro.2025.100343","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Sinonasal teratocar<strong>inosarcoma</strong> (SNTCS) is a rare and <strong>highly aggressive malignancy</strong> of the anterior skull base typically affecting the paranasal and ethmoidal sinuses. Histologically, SNTCS exhibits unique heterogeneous features having mixed characteristics of <strong>teratoma</strong> and <strong>carcinosarcoma</strong>. This complexity makes diagnosis challenging, often leading to delays in treatment. The first case of SNTCS was described in the literature in 1966 by Patchefsky et al. However the term “<strong>teratocarcinosarcoma</strong>” was coined 16 years later by Heffner and Hyams who outlined the unique heterogenic pathology of the disease in their analysis of 20 cases. The overall incidence of this tumor remains extremely low with less than <strong>150 cases reported</strong> in the literature, primarily consisting of single case reports or case series.</div></div><div><h3>Case report</h3><div>This case report details a rare instance of sinonasal teratocarcinosarcoma in a 15-year-old male who presented with nasal swelling. Imaging revealed polypoidal thickening in the sinuses, leading to surgical resection. Pathology indicated undifferentiated carcinoma with positive markers for teratocarcinosarcoma. After a year in remission, a local recurrence was noted, prompting additional surgery and adjuvant chemoradiotherapy. The patient completed radiotherapy and chemotherapy with no residual disease on follow-up imaging. He currently remains in remission under regular surveillance.</div></div><div><h3>Conclusion</h3><div>Sinonasal teratocarcinosarcoma (SNTCS), is known to be aggressive in nature leading to a poor prognosis. Aggressive tri-modality treatment is currently the most effective treatment with acceptable toxicity. The rarity of the condition underscores the need for further research to understand the genetic or environmental influences that may contribute to such atypical cases.</div></div>","PeriodicalId":101248,"journal":{"name":"The Royal College of Radiologists Open","volume":"3 ","pages":"Article 100343"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A teenage rarity: Sinonasal teratocarcinosarcoma in an adolescent and its clinical course\",\"authors\":\"Aqueel Shahid , Sadia Abdullah , Abbas Ali Hussain , Sadia Khan\",\"doi\":\"10.1016/j.rcro.2025.100343\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><div>Sinonasal teratocar<strong>inosarcoma</strong> (SNTCS) is a rare and <strong>highly aggressive malignancy</strong> of the anterior skull base typically affecting the paranasal and ethmoidal sinuses. Histologically, SNTCS exhibits unique heterogeneous features having mixed characteristics of <strong>teratoma</strong> and <strong>carcinosarcoma</strong>. This complexity makes diagnosis challenging, often leading to delays in treatment. The first case of SNTCS was described in the literature in 1966 by Patchefsky et al. However the term “<strong>teratocarcinosarcoma</strong>” was coined 16 years later by Heffner and Hyams who outlined the unique heterogenic pathology of the disease in their analysis of 20 cases. The overall incidence of this tumor remains extremely low with less than <strong>150 cases reported</strong> in the literature, primarily consisting of single case reports or case series.</div></div><div><h3>Case report</h3><div>This case report details a rare instance of sinonasal teratocarcinosarcoma in a 15-year-old male who presented with nasal swelling. Imaging revealed polypoidal thickening in the sinuses, leading to surgical resection. Pathology indicated undifferentiated carcinoma with positive markers for teratocarcinosarcoma. After a year in remission, a local recurrence was noted, prompting additional surgery and adjuvant chemoradiotherapy. The patient completed radiotherapy and chemotherapy with no residual disease on follow-up imaging. He currently remains in remission under regular surveillance.</div></div><div><h3>Conclusion</h3><div>Sinonasal teratocarcinosarcoma (SNTCS), is known to be aggressive in nature leading to a poor prognosis. Aggressive tri-modality treatment is currently the most effective treatment with acceptable toxicity. The rarity of the condition underscores the need for further research to understand the genetic or environmental influences that may contribute to such atypical cases.</div></div>\",\"PeriodicalId\":101248,\"journal\":{\"name\":\"The Royal College of Radiologists Open\",\"volume\":\"3 \",\"pages\":\"Article 100343\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Royal College of Radiologists Open\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2773066225001093\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Royal College of Radiologists Open","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2773066225001093","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
A teenage rarity: Sinonasal teratocarcinosarcoma in an adolescent and its clinical course
Introduction
Sinonasal teratocarinosarcoma (SNTCS) is a rare and highly aggressive malignancy of the anterior skull base typically affecting the paranasal and ethmoidal sinuses. Histologically, SNTCS exhibits unique heterogeneous features having mixed characteristics of teratoma and carcinosarcoma. This complexity makes diagnosis challenging, often leading to delays in treatment. The first case of SNTCS was described in the literature in 1966 by Patchefsky et al. However the term “teratocarcinosarcoma” was coined 16 years later by Heffner and Hyams who outlined the unique heterogenic pathology of the disease in their analysis of 20 cases. The overall incidence of this tumor remains extremely low with less than 150 cases reported in the literature, primarily consisting of single case reports or case series.
Case report
This case report details a rare instance of sinonasal teratocarcinosarcoma in a 15-year-old male who presented with nasal swelling. Imaging revealed polypoidal thickening in the sinuses, leading to surgical resection. Pathology indicated undifferentiated carcinoma with positive markers for teratocarcinosarcoma. After a year in remission, a local recurrence was noted, prompting additional surgery and adjuvant chemoradiotherapy. The patient completed radiotherapy and chemotherapy with no residual disease on follow-up imaging. He currently remains in remission under regular surveillance.
Conclusion
Sinonasal teratocarcinosarcoma (SNTCS), is known to be aggressive in nature leading to a poor prognosis. Aggressive tri-modality treatment is currently the most effective treatment with acceptable toxicity. The rarity of the condition underscores the need for further research to understand the genetic or environmental influences that may contribute to such atypical cases.